Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model.
about
Delayed graft function in the kidney transplantMolecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.Low-level laser therapy decreases renal interstitial fibrosis.Analysis of machine perfusion benefits in kidney grafts: a preclinical study.Contribution of large pig for renal ischemia-reperfusion and transplantation studies: the preclinical model.Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.Antithrombin nanoparticles improve kidney reperfusion and protect kidney function after ischemia-reperfusion injury.Role of warm ischemia on innate and adaptive responses in a preclinical renal auto-transplanted porcine model.miRNA profiling discriminates types of rejection and injury in human renal allograftsInhibition of complement improves graft outcome in a pig model of kidney autotransplantation.Diet-induced increase in plasma oxidized LDL promotes early fibrosis in a renal porcine auto-transplantation model.New strategies to optimize kidney recovery and preservation in transplantation.Strategies to optimize kidney recovery and preservation in transplantation: specific aspects in pediatric transplantation.Actions of thrombin in the interstitium.Gender-specific role of HDAC11 in kidney ischemia- and reperfusion-induced PAI-1 expression and injury.Thrombin may modulate dendritic cell activation in kidney transplant recipients with delayed graft function.Lysophosphatidic acid increases proximal tubule cell secretion of profibrotic cytokines PDGF-B and CTGF through LPA2- and Gαq-mediated Rho and αvβ6 integrin-dependent activation of TGF-βChronic renoprotective effect of pulsatile perfusion machine RM3 and IGL-1 solution in a preclinical kidney transplantation model.Targeting eIF5A Hypusination Prevents Anoxic Cell Death through Mitochondrial Silencing and Improves Kidney Transplant Outcome.Quantification of vascular damage in acute kidney injury with fluorine magnetic resonance imaging and spectroscopy.The Optimal PEG for Kidney Preservation: A Preclinical Porcine Study.Enhancing kidney function with thrombolytic therapy following donation after cardiac death: a multicenter quasi-blinded prospective randomized trial.Prevention of ischemia-reperfusion lung injury during static cold preservation by supplementation of standard preservation solution with HEMO2life® in pig lung transplantation model.Kidney graft outcome using an anti-Xa therapeutic strategy in an experimental model of severe ischaemia-reperfusion injury.Dose-ranging study of the performance of the natural oxygen transporter HEMO2 Life in organ preservation.Cyclodextrin curcumin formulation improves outcome in a preclinical pig model of marginal kidney transplantation.Supplementation with a new therapeutic oxygen carrier reduces chronic fibrosis and organ dysfunction in kidney static preservation.Targeting Complement Pathways During Cold Ischemia and Reperfusion Prevents Delayed Graft Function.Decreased expression of sirtuin 3 protein correlates with early stage chronic renal allograft dysfunction in a rat kidney model.
P2860
Q26824506-34CDDB1A-9FA9-493C-8F3A-380413014042Q33751106-3EE5C68F-247B-4DB9-A9C7-CFE6EFDE40CDQ34470104-8088D3F8-DBB4-41A6-9B84-D0FAC448279BQ34570605-C34F86A1-5F09-43A7-AE3F-AA46A7E09F97Q34635244-0CDB380F-529D-405F-989F-8BBF4552F0C7Q34917680-368694C3-9455-4CD3-8DA0-255BE0D0A9E7Q35274033-7CB04B14-65F4-4CA2-9B18-27989E64CCB4Q36884814-B842B8A4-0E3F-4818-B39E-B1EC7474251CQ36914549-8C765579-FA0D-4C82-B730-D14B2C97E108Q37280720-288B4CB5-58FF-43AA-8A40-608FC2C1C751Q37714689-3C9FB641-DEAF-44C4-9C17-27610C2D07EEQ38006826-AF5CB9B9-3FDC-4267-A322-7A84A88C6D4AQ38245855-7AE42804-9B96-4819-A2F5-30DBABDB09CCQ38632366-20B1B50A-FF90-4E88-9EE3-F968B3873BC1Q39154615-F60BDFDE-D017-4EBA-9800-7C66B37C0977Q40856216-AA213D70-4947-4C79-8DA8-8005BEBDBCD5Q42044693-2C239E9A-FF7F-4A75-96AA-15203B05C9EAQ42200808-C4CA4EEE-3EAB-4046-A676-383CB0AF9346Q46491554-66DA977A-5E66-44A6-AD2C-0E08433606CEQ47338726-2C9C2260-966A-4567-B859-04ECB13249EAQ48104974-46204035-0DB6-4BE6-9097-AD678875CFD6Q48122451-441185D8-DF90-45B6-A7DC-56CBF92D2B7CQ50083397-F95F9A3A-0605-4943-85BB-913658541EE1Q50612339-AB9F6FE9-866D-4F4E-AE8C-2F35EB4ADF52Q50696120-AB55C09B-0999-4012-AAD8-C2DD46F3DC85Q50711738-DFF02B48-1C5F-4CC8-8C6D-F02BCEC77E76Q51012535-6B9DE23C-EBE8-4CD1-A44E-6A1783D7096CQ53761556-00912109-0A87-414A-9CC1-B2A3F9C961B3Q55334450-91AD11F1-D422-453A-85BF-6A62813D0BAA
P2860
Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Anti-thrombin therapy during w ...... graft fibrosis in a DCD model.
@ast
Anti-thrombin therapy during w ...... graft fibrosis in a DCD model.
@en
type
label
Anti-thrombin therapy during w ...... graft fibrosis in a DCD model.
@ast
Anti-thrombin therapy during w ...... graft fibrosis in a DCD model.
@en
prefLabel
Anti-thrombin therapy during w ...... graft fibrosis in a DCD model.
@ast
Anti-thrombin therapy during w ...... graft fibrosis in a DCD model.
@en
P2093
P2860
P1476
Anti-thrombin therapy during w ...... graft fibrosis in a DCD model.
@en
P2093
R Thuillier
P2860
P356
10.1111/J.1600-6143.2009.02924.X
P407
P577
2009-12-02T00:00:00Z